Diagnostic Efficacy Of 3 EUS-FNB Techniques

Launched by HOSPITAL UNIVERSITARIO INSULAR GRAN CANARIA · Apr 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying three different techniques for a procedure called endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB), which helps doctors collect samples from suspicious lesions in the abdomen for diagnosis. The goal is to find out which technique—dry puncture, slow-pull, or wet puncture—works best for getting accurate samples for testing. This is important because having the right samples can lead to better diagnoses and treatment plans for patients with conditions like pancreatic cancer and other abdominal issues.

To participate in the study, patients need to be at least 18 years old and have been referred for this procedure after imaging tests (like CT or MRI) have shown lesions larger than 1 cm. However, those with certain medical conditions or who are on specific medications may not be eligible. Participants will receive the treatment according to one of the three techniques being studied and will help researchers understand which method is most effective. This trial is currently recruiting, and your involvement could contribute to improving diagnostic practices in the future.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • Age ≥ 18 years
• • Patients referred for EUS-FNB after imaging tests (CT, MRI, or abdominal ultrasound) of pancreatic, non-pancreatic intraabdominal, mediastinal, or pelvic lesions greater than 1 cm.
• • Signed informed consent.
• • Exclusion criteria
• • Coagulopathy (INR\> 1.5) or thrombocytopenia (\<50,000)
• • Severe heart or respiratory failure that contraindicates sedation.
• • Use of anticoagulants and antiplatelet agents that cannot be suspended.
• • Use of a needle of a different gauge to 22G
• • Refusal to sign informed consent.